susana frazao pinheiro

Investment advisor to the european union and european innovation funds; lead, healthcare and life sciences, university college london school of management

Susana trained as a microbiologist; she has conducted research in HIV immunology in Oxford, the Medical Research Council in The Gambia and the NIH (Fort Detrick) in the USA, presenting her work at several international conferences and publishing in scientific journals. After a PhD in Clinical Medicine at the University of Oxford, she acted as Postdoctoral Research Fellow and Analytical Project Manager in a Phase-I clinical trial for an HIV vaccine conducted at Oxford and funded by IAVI. Her search for solutions to the HIV epidemic led her to pursue an MBA at Said Business School, University of Oxford (as Skoll scholar in social entrepreneurship) to start an initiative using mobile phones for health outreach in The Gambia in 2007. She has been involved in several entrepreneurial ventures, as co-founder and Executive Director of IES - Institute for Social Entrepreneurship in Portugal, now Social Business School and as founding committee of Oxford Entrepreneurs. She acted as Secretary, Oxford University Strategic Studies Group. After the earthquake in Haiti, Susana travelled to the country over two years to work with locals to develop an innovative real-time, data-driven epidemiological surveillance system, co-funded by the European Space Agency that led her to be named Social Capital Markets Entrepreneur 2012 (San Francisco).

She has spent over a decade working in health policy with the UN (Peacekeeping Financing Division, Department of Peacekeeping Operations in New York, UNDP Geneva and Angola and UNAIDS Angola), and with Ministries of Health in Europe and in Africa.

During this time, Susana maintained invited professor roles and in 2014 she joined UCL to design and lead an innovative Healthcare and Life Sciences Initiative at the School of Management; she teaches at the UCL Medical School and School of Pharmacy.

Susana also works with the EU and Innovation Funds on the assessment of health innovation and technology and acts as scientific advisor, Blavatnik School of Government, University of Oxford. She seats on the Advisory Boards of the Institute of Global Health Georgia and of the Center for Business and Poverty, Oxford.